Client NewsRoquefort Therapeutics plc: Board and Management Appointments
Roquefort Therapeutics (LSE:ROQ,OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class drugs in the high value and high growth oncology segment, is pleased to announce that further to the completion of its acquisition of the entire issued share capital of Oncogeni Limited (“Oncogeni”) as announced earlier today the following board appointments:
OPEN AN ACCOUNT
If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.
Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.